Article
Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus.
The Journal of infectious diseases - 1 Nov 1998
Gubareva L V, Matrosovich M N, Brenner M K, Bethell R C, Webster R G
Abstract excerpt
Zanamivir, a neuraminidase inhibitor, has shown promise as a drug to control influenza. During prolonged treatment with zanamivir, a mutant virus was isolated from an immunocompromised child infected with influenza B virus. A hemagglutinin mutation (198 Thr-->Ile) reduced the virus affinity for receptors found on susceptible human cells. A mutation in the neuraminidase active site (152 Arg-->Lys) led to a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
